Evidence map›Paper›PMID 35997680›Full record

ArticleThe Journal of experimental medicine2022

Thymic epithelial cells require lipid kinase Vps34 for CD4 but not CD8 T cell selection.

J Luke Postoak, Wenqiang Song, Guan Yang, Xingyi Guo, Shiyun Xiao, Cherie E Saffold, Jianhua Zhang, Sebastian Joyce, Nancy R Manley, Lan Wu and 1 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. The Ins and Outs of Thymic Epithelial Cell Differentiation and Function.Advances in experimental medicine and biology · 2025
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. The thymoproteasome in shaping the CD8Current opinion in immunology · 2023
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

J Luke PostoakDepartment of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN.ORCID 0000-0002-2891-9938
Wenqiang SongDepartment of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN.ORCID 0000-0002-3918-7007
Guan YangDepartment of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN.ORCID 0000-0002-2131-8435
Xingyi GuoDepartment of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN.ORCID 0000-0001-5269-1294
Shiyun XiaoDepartment of Genetics, University of Georgia, Athens, GA.ORCID 0000-0003-0196-287X
Cherie E SaffoldDepartment of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN.ORCID 0000-0002-0347-2068
Jianhua ZhangDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL.ORCID 0000-0002-7218-1977
Sebastian JoyceDepartment of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN.ORCID 0000-0002-3183-1451
Nancy R ManleyDepartment of Genetics, University of Georgia, Athens, GA.ORCID 0000-0001-8489-7764
Lan WuDepartment of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN.ORCID 0000-0002-1966-2501
Luc Van KaerDepartment of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN.ORCID 0000-0001-5275-2309
Vanderbilt University · USUniversity of Georgia · USUniversity of Alabama at Birmingham · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
Immunobiology of Blood and Vascular Systems Training ProgramT32HL069765 · NHLBI · VANDERBILT UNIVERSITY · PI HAWIGER, JACK J · 2002 to 2016
$6.5M
Interdisciplinary Training in Rheumatic DiseasesT32AR059039 · NIAMS · VANDERBILT UNIVERSITY · PI Tracy Minan Frech, AMY S MAJOR · 2010 to 2026
$4.3M
Role of autophagy-related protein Vps34 in antigen presentation and self-toleranceR01AI139046 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI VAN KAER, LUC · 2019 to 2023
$2.2M
Molecular Basis of CD1D and Natural Killer T Cell FunctionR01AI137082 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI JOYCE, SEBASTIAN · 2019 to 2022
$2.1M
iCD8alpha cells as novel innate-type lymphoid cells that mediate gut immunityR01DK104817 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI VAN KAER, LUC · 2015 to 2018
$1.3M
Vaccinating at Mucosal Surfaces with Nanoparticle Conjugated Antigen and AdjuvantI01BX001444 · VA · VETERANS HEALTH ADMINISTRATION · PI JOYCE, SEBASTIAN · 2014 to 2022
–
BLRD Research Career Scientist Award ApplicationIK6BX004595 · VA · VETERANS HEALTH ADMINISTRATION · PI JOYCE, SEBASTIAN · 2019 to 2025
–
American Heart Association-American Stroke Association 19TPA34910078BLRD VA I01 BX001444BLRD VA I01 BX006010BLRD VA IK6 BX004595NCI NIH HHS P30 CA068485NHLBI NIH HHS T32 HL069765NIAID NIH HHS R01 AI137082NIAID NIH HHS R01 AI139046NIAMS NIH HHS T32 AR059039NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P30 DK058404NIDDK NIH HHS R01 DK104817
6 · The paper itself

Abstract

The generation of a functional, self-tolerant T cell receptor (TCR) repertoire depends on interactions between developing thymocytes and antigen-presenting thymic epithelial cells (TECs). Cortical TECs (cTECs) rely on unique antigen-processing machinery to generate self-peptides specialized for T cell positive selection. In our current study, we focus on the lipid kinase Vps34, which has been implicated in autophagy and endocytic vesicle trafficking. We show that loss of Vps34 in TECs causes profound defects in the positive selection of the CD4 T cell lineage but not the CD8 T cell lineage. Utilizing TCR sequencing, we show that T cell selection in conditional mutants causes altered repertoire properties including reduced clonal sharing. cTECs from mutant mice display an increased abundance of invariant chain intermediates bound to surface MHC class II molecules, indicating altered antigen processing. Collectively, these studies identify lipid kinase Vps34 as an important contributor to the repertoire of selecting ligands processed and presented by TECs to developing CD4 T cells.

Indexed as

CD8-Positive T-LymphocytesLymphocyte ActivationAnimalsCD8 AntigensClass III Phosphatidylinositol 3-KinasesEpithelial CellsLipidsMiceMice, Inbred C57BLReceptors, Antigen, T-CellThymus GlandCD8 AntigensClass III Phosphatidylinositol 3-KinasesLipidsPIK3C3 protein, mouseReceptors, Antigen, T-Cell

Identifiers

PMID35997680
PMCPMC9402993
OpenAlexW4292722731

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.